Bayer’s Cipro Patent Case , Schutt, Sharron Angle: Intellectual Property

A U.S. appeals court refused to reconsider whether a patent settlement reached by Bayer AG over the anthrax treatment Cipro was appropriate, a setback in the government’s efforts to curb such deals. (42 mins ago)

Tags: , , , , , , ,

One Response to “Bayer’s Cipro Patent Case , Schutt, Sharron Angle: Intellectual Property”

  1. LucKy232 says:

    A US appeal court refused to consider a settlement over the anthrax treatment Cipro.
    Furthermore, the Second US Circuit Court of Appeal denied a request saying that judges should consider the standard antitrust laws in the agreement.
    Judges say that the full appeal courts should take the case